227 related articles for article (PubMed ID: 16827770)
1. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
MacKenzie IZ; Findlay J; Thompson K; Roseman F
BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770
[TBL] [Abstract][Full Text] [Related]
2. Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: results of a longitudinal study.
Mackenzie IZ; Roseman F; Findlay J; Thompson K; McPherson K
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):38-42. PubMed ID: 18243487
[TBL] [Abstract][Full Text] [Related]
3. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
Chaffe B; Ford J; Bills V
Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin.
MacKenzie IZ; Roseman F; Findlay J; Thompson K; Jackson E; Scott J; Reed M
BJOG; 2006 Jan; 113(1):97-101. PubMed ID: 16398777
[TBL] [Abstract][Full Text] [Related]
5. An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside.
Rennie I; Smith A; Smith R; Rawlinson PS; Clark P
Health Bull (Edinb); 2001 May; 59(3):150-4. PubMed ID: 12664753
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
Larsen JF; Bock JE; Jørgensen JR
Ugeskr Laeger; 2004 Aug; 166(36):3078-83. PubMed ID: 15387304
[No Abstract] [Full Text] [Related]
7. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
8. Evidence to support the single-dose over the two-dose protocol for routine antenatal anti-D Rhesus prophylaxis: a prospective observational study.
MacKenzie IZ; Dutton S; Roseman F
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):42-6. PubMed ID: 21641101
[TBL] [Abstract][Full Text] [Related]
9. The use of anti-D immunoglobulins for rhesus prophylaxis: audit on knowledge and practices among obstetricians.
Wee WW; Kanagalingam D
Singapore Med J; 2009 Nov; 50(11):1054-7. PubMed ID: 19960158
[TBL] [Abstract][Full Text] [Related]
10. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
[TBL] [Abstract][Full Text] [Related]
11. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
12. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis.
Tuohy JF; Sangalli M; Kim L
Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
Larsen JF; Bock JE; Jørgensen JR
Ugeskr Laeger; 2004 Aug; 166(36):3073-8. PubMed ID: 15387303
[No Abstract] [Full Text] [Related]
14. Incidence of maternal sensitisation to Rh(D) in Christchurch, New Zealand and reasons for prophylaxis failures.
Badami KG; Parker J; Kenny A; Warrington S
N Z Med J; 2014 Jan; 127(1388):40-6. PubMed ID: 24481385
[TBL] [Abstract][Full Text] [Related]
15. [Recommendations for clinical practice. Prevention in maternofetal Rh immunization (December 2005)].
Collège National des Gynécologues et Obstétriciens Français
Gynecol Obstet Fertil; 2006 Apr; 34(4):360-5. PubMed ID: 16644259
[No Abstract] [Full Text] [Related]
16. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
[No Abstract] [Full Text] [Related]
17. [Clinical guidelines on anti-D prophylaxis: hasty critics?].
Carbonne B; Marpeau L; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):526-8. PubMed ID: 17893030
[No Abstract] [Full Text] [Related]
18. [Comparison of the efficacy of different methods for the prevention of anti-D allo-immunization during pregnancy: targeted strategy limited to risk situations or associated with systematic prevention in the 3rd trimester].
Parant O
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S93-1S103. PubMed ID: 16495834
[TBL] [Abstract][Full Text] [Related]
19. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
[No Abstract] [Full Text] [Related]
20. Anti-D immunoglobulin prophylaxis--are we doing enough?
Drug Ther Bull; 1985 Dec; 23(24):93-5. PubMed ID: 2998720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
